An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing With Concurrent Controls in Platform Trials
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Tianyu Zhan, Jane Zhang, Lei Shu, Yihua Gu |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing with Concurrent Controls in Platform Trials
by: Zhan, Tianyu, et al.
Published: (2025)
by: Zhan, Tianyu, et al.
Published: (2025)
Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
by: Tianyu Zhan, et al.
Published: (2026)
by: Tianyu Zhan, et al.
Published: (2026)
On the Inclusion of Non‐Concurrent Controls in Platform Trials With an Interim Analysis
by: Pavla Krotka, et al.
Published: (2026)
by: Pavla Krotka, et al.
Published: (2026)
Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation
by: Junichi Asano, et al.
Published: (2026)
by: Junichi Asano, et al.
Published: (2026)
Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial
by: Fei Heng, et al.
Published: (2025)
by: Fei Heng, et al.
Published: (2025)
A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
by: Tianyu Zhan
Published: (2024)
by: Tianyu Zhan
Published: (2024)
Semiparametric Estimation of Relative Causal Effects in Randomized Controlled Trials With Noncompliance
by: Wenli Liu, et al.
Published: (2025)
by: Wenli Liu, et al.
Published: (2025)
A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives
by: Antonio Olivas‐Martinez, et al.
Published: (2026)
by: Antonio Olivas‐Martinez, et al.
Published: (2026)
Testing for Similarity of Dose Response in Multiregional Clinical Trials
by: Holger Dette, et al.
Published: (2025)
by: Holger Dette, et al.
Published: (2025)
Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
by: Ethan Ashby, et al.
Published: (2025)
by: Ethan Ashby, et al.
Published: (2025)
A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting
by: Niki Z. Petrakos, et al.
Published: (2025)
by: Niki Z. Petrakos, et al.
Published: (2025)
Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
by: Fei Gao, et al.
Published: (2025)
by: Fei Gao, et al.
Published: (2025)
A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
by: Yichen Yan, et al.
Published: (2025)
by: Yichen Yan, et al.
Published: (2025)
Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
by: Shu Jiang, et al.
Published: (2025)
by: Shu Jiang, et al.
Published: (2025)
Integrating Complex Selection Rules Into the Latent Overlapping Group Lasso for the Construction of Coherent Prediction Models
by: Guanbo Wang, et al.
Published: (2025)
by: Guanbo Wang, et al.
Published: (2025)
Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
by: Yunyi Liu, et al.
Published: (2026)
by: Yunyi Liu, et al.
Published: (2026)
Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
by: Kim May Lee, et al.
Published: (2026)
by: Kim May Lee, et al.
Published: (2026)
Score Test for Functional Markov Process With Image Predictor
by: Yang Wang, et al.
Published: (2025)
by: Yang Wang, et al.
Published: (2025)
Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials
by: Godwin Yung, et al.
Published: (2025)
by: Godwin Yung, et al.
Published: (2025)
A Saddlepoint Framework for Accurate Inference in Multicenter Clinical Trials With Imbalanced Clusters
by: Haidy A. Newer
Published: (2026)
by: Haidy A. Newer
Published: (2026)
Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
by: Jiaqi Tong, et al.
Published: (2025)
by: Jiaqi Tong, et al.
Published: (2025)
Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
by: Xi Fang, et al.
Published: (2026)
by: Xi Fang, et al.
Published: (2026)
Dynamic Borrowing With a Bias‐Tolerance Cap in Augmented Randomized Controlled Trials
by: Kota Sawada, et al.
Published: (2026)
by: Kota Sawada, et al.
Published: (2026)
Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
by: Jingyan Fu, et al.
Published: (2025)
by: Jingyan Fu, et al.
Published: (2025)
Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
by: Antonio D'Alessandro, et al.
Published: (2026)
by: Antonio D'Alessandro, et al.
Published: (2026)
Estimation and Inference for the Additive Mean Residual Life Model With Change Point in the Continuous Covariate
by: Yun Lin, et al.
Published: (2025)
by: Yun Lin, et al.
Published: (2025)
Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
by: Daniel E. Schwartz, et al.
Published: (2026)
by: Daniel E. Schwartz, et al.
Published: (2026)
Permutation Tests Based on the Copula‐Graphic Estimator and Their Use for Survival Tree Construction
by: Pauline Baur, et al.
Published: (2026)
by: Pauline Baur, et al.
Published: (2026)
A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards
by: Florian Klinglmüller, et al.
Published: (2025)
by: Florian Klinglmüller, et al.
Published: (2025)
Optimal Control of Directional False Discovery Rates in Large‐Scale Testing
by: Guozhu Tang, et al.
Published: (2025)
by: Guozhu Tang, et al.
Published: (2025)
Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior
by: Zifei Han, et al.
Published: (2025)
by: Zifei Han, et al.
Published: (2025)
Futility Monitoring in Clinical Trials
by: Ana M. Ortega‐Villa, et al.
Published: (2025)
by: Ana M. Ortega‐Villa, et al.
Published: (2025)
Cluster‐Level Analyses to Estimate a Risk Difference in a Cluster Randomized Trial With Confounding Individual‐Level Covariates: A Simulation Study
by: Jules Antoine Pereira Macedo, et al.
Published: (2025)
by: Jules Antoine Pereira Macedo, et al.
Published: (2025)
Integrative Multi‐Omics and Multivariate Longitudinal Data Analysis for Dynamic Risk Estimation in Alzheimer's Disease
by: Yuanyuan Guo, et al.
Published: (2025)
by: Yuanyuan Guo, et al.
Published: (2025)
What's the Weight? Estimating Controlled Outcome Differences in Complex Surveys for Health Disparities Research
by: Stephen Salerno, et al.
Published: (2025)
by: Stephen Salerno, et al.
Published: (2025)
The Design of Large‐Scale Plasma Donation Trials
by: Kecheng Li, et al.
Published: (2025)
by: Kecheng Li, et al.
Published: (2025)
Model‐Robust Standardization in Cluster‐Randomized Trials
by: Fan Li, et al.
Published: (2025)
by: Fan Li, et al.
Published: (2025)
Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting
by: Masahiro Kojima, et al.
Published: (2026)
by: Masahiro Kojima, et al.
Published: (2026)
RMST for Interval‐Censored Data in Oncology Clinical Trials
by: Xiyuan Gao, et al.
Published: (2025)
by: Xiyuan Gao, et al.
Published: (2025)
An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials
by: Erik W. van Zwet, et al.
Published: (2026)
by: Erik W. van Zwet, et al.
Published: (2026)
Similar Items
-
An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing with Concurrent Controls in Platform Trials
by: Zhan, Tianyu, et al.
Published: (2025) -
Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
by: Tianyu Zhan, et al.
Published: (2026) -
On the Inclusion of Non‐Concurrent Controls in Platform Trials With an Interim Analysis
by: Pavla Krotka, et al.
Published: (2026) -
Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation
by: Junichi Asano, et al.
Published: (2026) -
Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial
by: Fei Heng, et al.
Published: (2025)